# Bio-Thera Announces NMPA Approval of BAT2506, the First Golimumab Biosimilar Approved in China

- Source: PR Newswire M&A
- Published: 2026-11-06T12:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/bio-thera-announces-nmpa-approval-of-bat2506-the-first-golimumab-biosimilar-approved-in-china-302931732.html
- Canonical: https://groundlevelnews.com/story/bio-thera-announces-nmpa-approval-of-bat2506-the-first-golimumab-biosi-0d08b9/

GUANGZHOU, China, Nov. 6, 2026 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced that the National Medical Products Administration (NMPA) has approved its marketing...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._